Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome
出版年份 2017 全文链接
标题
Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome
作者
关键词
-
出版物
Arthritis & Rheumatology
Volume 69, Issue 8, Pages 1679-1688
出版商
Wiley
发表日期
2017-05-09
DOI
10.1002/art.40146
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome
- (2017) Seza Ozen et al. ARTHRITIS CARE & RESEARCH
- Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
- (2016) Marco Gattorno et al. ANNALS OF THE RHEUMATIC DISEASES
- Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
- (2016) Romain Banchereau et al. CELL
- Control of the innate immune response by the mevalonate pathway
- (2016) Murali K Akula et al. NATURE IMMUNOLOGY
- Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS
- (2016) Yong Hwan Park et al. NATURE IMMUNOLOGY
- Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes
- (2016) Torbjörn Kullenberg et al. RHEUMATOLOGY
- The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry
- (2016) Nienke M. ter Haar et al. Arthritis & Rheumatology
- Quantitative gene set analysis generalized for repeated measures, confounder adjustment, and continuous covariates
- (2015) Jacob A. Turner et al. BMC BIOINFORMATICS
- Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience
- (2015) Svetlana Kostjukovits et al. EUROPEAN JOURNAL OF PEDIATRICS
- Treatment of adult hyper-IgD syndrome with canakinumab
- (2015) Casey D. Curtis et al. Journal of Allergy and Clinical Immunology-In Practice
- A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease
- (2014) Cailin H Sibley et al. ANNALS OF THE RHEUMATIC DISEASES
- Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature
- (2014) Raquel Campanilho-Marques et al. CLINICAL RHEUMATOLOGY
- Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
- (2014) Katrin D. Mayer-Barber et al. NATURE
- 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon
- (2014) A. Reboldi et al. SCIENCE
- Canakinumab for the Treatment of Children With Colchicine-Resistant Familial Mediterranean Fever: A 6-Month Open-Label, Single-Arm Pilot Study
- (2014) Riva Brik et al. Arthritis & Rheumatology
- Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
- (2014) Norman T. Ilowite et al. Arthritis & Rheumatology
- Quantitative set analysis for gene expression: a method to quantify gene set differential expression including gene-gene correlations
- (2013) Gur Yaari et al. NUCLEIC ACIDS RESEARCH
- Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial
- (2012) H. Ralph Schumacher et al. ARTHRITIS AND RHEUMATISM
- Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study
- (2012) Hal M. Hoffman et al. CLINICAL THERAPEUTICS
- Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
- (2012) Nicolino Ruperto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency
- (2012) C. Galeotti et al. RHEUMATOLOGY
- Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
- (2011) J. B. Kuemmerle-Deschner et al. ANNALS OF THE RHEUMATIC DISEASES
- On-demand anakinra treatment is effective in mevalonate kinase deficiency
- (2011) E. J. Bodar et al. ANNALS OF THE RHEUMATIC DISEASES
- Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
- (2011) Greta Guarda et al. IMMUNITY
- Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice
- (2011) Omar M. Khan et al. JOURNAL OF CLINICAL INVESTIGATION
- A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
- (2010) P. Quartier et al. ANNALS OF THE RHEUMATIC DISEASES
- An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
- (2010) Matthew P. R. Berry et al. NATURE
- Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
- (2009) Helen J. Lachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome
- (2008) Raphaela Goldbach-Mansky et al. ARTHRITIS AND RHEUMATISM
- A Modular Analysis Framework for Blood Genomics Studies: Application to Systemic Lupus Erythematosus
- (2008) Damien Chaussabel et al. IMMUNITY
- Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome
- (2008) Jeroen C. H. van der Hilst et al. MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now